EchoSolv AS vs KardiaAI
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department or echocardiography lab needs to efficiently and accurately identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This FDA-cleared, AI-powered platform integrates seamlessly into PACS workflows, providing consistent severe AS probability and guideline checks in under three seconds, thereby enhancing clinical review and prioritizing urgent cases.
View EchoSolv AS →Choose KardiaAI if…
Choose KardiaAI if you require an AI-powered solution for analyzing ambulatory ECG rhythms to detect a wide range of cardiac conditions, including atrial fibrillation, bradycardia, and tachycardia. This medical-grade AI software library is ideal for integration into mobile apps, web platforms, or other ECG devices, enabling remote patient monitoring and early detection of various arrhythmias.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | Cloud-based | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS is designed for minimal workflow disruption, explicitly stating 'no EMR integration required' and 'integrates with PACS,' alongside ultra-fast risk detection in under 3 seconds. This indicates a simpler and quicker integration process for clinicians within existing hospital workflows. KardiaAI, while offering an API for integration, relies on mobile and web platforms whose ultimate clinical usability depends on specific implementations.
Clinical Value
EchoSolv ASBoth tools are FDA-cleared and offer medical-grade accuracy. EchoSolv AS provides highly specialized and accurate risk identification for severe aortic stenosis, a critical and often underdiagnosed condition, with studies demonstrating near-perfect accuracy. KardiaAI offers broader utility by detecting a range of common cardiac arrhythmias from ECGs, which is valuable for screening and monitoring across various specialties.
Pricing & Value
KardiaAIKardiaAI offers transparent, accessible consumer-level subscription pricing (e.g., KardiaCare Monthly: $13.99/month), providing clear value for individual users or smaller practices. EchoSolv AS, as an enterprise solution, operates on a subscription-based model for hospitals with reimbursement via specific codes, but its pricing is not publicly disclosed, making direct comparison difficult.
Enterprise Readiness
EchoSolv ASBoth tools possess essential compliance (FDA-cleared, HIPAA compliant, BAA available). EchoSolv AS demonstrates strong enterprise readiness through its explicit design for PACS integration, minimal workflow disruption in hospital settings, and successful deployment in major health systems like Mount Sinai. While KardiaAI's API offers integration flexibility, EchoSolv AS is more explicitly tailored for direct enterprise deployment within existing hospital infrastructure.
Innovation
EchoSolv ASEchoSolv AS presents a distinct technical innovation with its measurement-based AI approach to echocardiogram analysis for severe aortic stenosis, specifically noting that its AI 'does not use LVOT measurements'. This addresses a complex diagnostic challenge in a novel way. While KardiaAI offers valuable AI-powered ECG analysis and newer generative AI features like AskKardia, EchoSolv AS's core diagnostic methodology for sAS appears more fundamentally innovative in its specialized application.
Support & Docs
KardiaAIKardiaAI provides more publicly visible and comprehensive support resources, including extensive FAQs, user manuals, troubleshooting guides, and direct contact options (phone, email) on its website. EchoSolv AS, as an enterprise solution, likely offers contractual support, but less public documentation is readily available for general users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | KardiaAI |
|---|---|---|
| Primary Focus | AI-powered clinical decision support for severe aortic stenosis (sAS) probability from echocardiograms. | AI software library for analyzing ambulatory ECG rhythms to detect various cardiac conditions. |
| Company | Echo IQ | AliveCor |
| Analyzed Data Type | Echocardiogram measurements (numerical, not images) | Ambulatory ECG rhythms |
| Detected Conditions | Severe Aortic Stenosis (sAS) probability | Atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE) |
| Integration Capabilities | Designed to fit existing workflows (no EMR integration required, integrates with PACS) | API library for integration into other ECG devices and software |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring EchoSolv AS or KardiaAI
Backers
Who funded each tool's parent company.